Low-Dose Hydrocortisone Therapy Attenuates Septic Shock in Adult Patients but Does Not Reduce 28-Day Mortality
Authors:
- Changsong WangCWChangsong Wang
- Jiaxiao SunJSJiaxiao Sun
- Juanjuan ZhengJZJuanjuan Zheng
- Lei GuoLGLei Guo
- Hongyan MaHMHongyan Ma
- Yang ZhangYZYang Zhang
- Fengmin ZhangFZFengmin Zhang
- Enyou LiELEnyou Li
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 118 (2) , 346-357
Abstract
The role of low-dose hydrocortisone in attenuating septic shock and reducing short-term mortality in adult patients with septic shock is unclear. We conducted a meta-analysis of previous studies to determine whether hydrocortisone could ameliorate the effects of septic shock at 7 and 28 days and reduce 28-day morality. Randomized controlled trials (RCTs) of corticosteroids versus placebo (or supportive treatment alone) were retrieved from electronic searches (Medline, Embase, and Cochrane Library databases; LILACS; and Web of Knowledge) and manual searches (up to May 2012). From a pool of 1949 potentially relevant articles, duplicate independent review identified 10 relevant, RCTs of low-dose hydrocortisone therapy in septic shock. Four pairs of reviewers agreed on the criteria for trial eligibility. One reviewer entered the data into the computer, and 3 reviewers checked the data. Missing data were obtained from the authors of the relevant trials. The primary outcome analyzed was an estimate of 28-day mortality. Eight publications were included in the meta-analysis. Low-dose hydrocortisone therapy did not reduce 28-day mortality (N = 1063; odds ratio (OR) = 0.891, 95% confidence interval (CI), 0.69–1.15). Low-dose hydrocortisone therapy ameliorated shock at 7 days (6 RCTs, N = 964, OR = 2.078, 95% CI, 1.58–2.73, P < 0.0001, and I2 = 26.9%) and 28 days (6 RCTs, N = 947, OR = 1.495, 95% CI, 1.12–1.99, P = 0.006, and I2 = 0.0%). Although low-dose hydrocortisone therapy ameliorates septic shock at 7 and 28 days, it does not reduce 28-day mortality.Keywords
This publication has 53 references indexed in Scilit:
- Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trialCanadian Medical Association Journal, 2010
- Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspectiveCritical Care, 2010
- Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registryCritical Care, 2010
- Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysisBMJ, 2008
- Comparison of C‐Reactive Protein and Serum Amyloid A Protein in Septic Shock PatientsMediators of Inflammation, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Cumulative meta-analysis of clinical trials builds evidence for exemplary medical careJournal of Clinical Epidemiology, 1995
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shockLife Sciences, 1984